Yann Jamin Selected Research

Yann Jamin Research Topics

Disease

33	Neoplasms (Cancer) 10/2023 - 05/2009
19	Neuroblastoma 10/2023 - 11/2011
5	Hypoxia (Hypoxemia) 01/2018 - 11/2011
3	Breast Neoplasms (Breast Cancer) 06/2023 - 11/2019
2	Necrosis 10/2022 - 10/2012
2	Prostatic Neoplasms (Prostate Cancer) 09/2021 - 10/2016
2	Prolactinoma (Prolactinomas) 09/2013 - 08/2013
2	Glioma (Gliomas) 10/2012 - 11/2011
1	Neoplasm Metastasis (Metastasis) 06/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Hemorrhage 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Hyperoxia 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2017
1	Retinoblastoma (Glioblastoma, Retinal) 11/2015
1	Colorectal Neoplasms (Colorectal Cancer) 10/2013

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2009
4	pimonidazoleIBA 01/2018 - 11/2011
4	Oxygen (Dioxygen)IBA 01/2018 - 08/2013
4	carbogenIBA 10/2016 - 10/2012
3	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2013
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2011
3	cediranib (AZD2171)IBA 01/2019 - 10/2012
3	CrizotinibIBA 01/2017 - 07/2012
3	EnzymesIBA 10/2013 - 05/2009
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2023 - 11/2020
2	N-acetylcochinol-O-phosphateIBA 10/2022 - 01/2013
2	CollagenIBA 11/2019 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2016
2	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2018 - 10/2012
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 10/2016 - 10/2012
2	N-Myc Proto-Oncogene ProteinIBA 01/2016 - 11/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2023
1	palbociclibIBA 10/2023
1	Hyaluronic Acid (Hyaluronan)IBA 06/2023
1	lorlatinibIBA 01/2023
1	RG7388IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	dehydronifedipineIBA 09/2021
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	Temozolomide (Temodar)FDA LinkGeneric 11/2020
1	CYC065IBA 11/2020
1	olaparibIBA 06/2020
1	niraparibIBA 06/2020
1	talazoparibIBA 06/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2020
1	veliparibIBA 06/2020
1	MLN 8237IBA 01/2020
1	Aurora Kinase AIBA 01/2020
1	vistusertibIBA 01/2020
1	Collagenases (Collagenase)FDA Link 11/2019
1	Thymidine KinaseIBA 10/2019
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	CyclinsIBA 10/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Contrast MediaIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	ceritinibIBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Melanins (Melanin)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	tanespimycin (17AAG)IBA 01/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017
1	VemurafenibIBA 01/2017
1	Hydralazine (Apresoline)FDA LinkGeneric 02/2016
1	AntioxidantsIBA 01/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	MTOR InhibitorsIBA 01/2016
1	Oncogene Proteins (Oncogene Protein)IBA 01/2016
1	Buthionine SulfoximineIBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2015
1	NucleophosminIBA 11/2015
1	Cyclin-Dependent Kinase 2IBA 11/2015
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 11/2015
1	SolutionsIBA 04/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	Pyruvic Acid (Pyruvate)IBA 10/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2013

Therapy/Procedure

18	Therapeutics 01/2023 - 11/2009
3	Aftercare (After-Treatment) 11/2015 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2023 - 11/2009
2	Combined Modality Therapy 01/2022 - 11/2015
2	Precision Medicine 01/2020 - 01/2019
1	Induction Chemotherapy 01/2023
1	Intravenous Administration 10/2016